TirzepatideRanked
Find my match
Price index re-read 2026-10-15 NexLife prices 2026-11-06 Methodology v4.1 Programs priced 28 Corrections open log

Head to head

Found vs Lavender Sky Health: Pricing, Evidence and What Neither Discloses

We hold captured pricing for Found only, so a like-for-like price comparison is not possible yet.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

We hold captured pricing for Found only, so a like-for-like price comparison is not possible yet. Both providers' undisclosed fields are shown below rather than omitted, and neither has named its fulfilling pharmacy to us.

Answer last reviewed:

The short answer

We hold captured pricing for Found only, so a like-for-like price comparison is not possible yet. Both figures are provider-reported.

Price is one of five fields that matter, and it is the only one either company reliably publishes. The others — which pharmacy fills the prescription, whether the price holds as your dose rises, what is refunded if you stop, and whether the programme can lawfully serve your state — are unverified for both.

Compare at a maintenance dose, not at signup

The tirzepatide label describes 2.5 mg as treatment initiation and states it is not approved as a maintenance dosage. You take it for four weeks and then never again. Where a programme tiers by dose, the advertised figure is usually that starting dose — so a comparison built on it ranks these two on a price neither charges after month one.

Ask both for the all-in monthly cost at 10 mg, which is a recommended maintenance dosage, and compare those.

What neither has told us

Neither Found nor Lavender Sky Health has named its fulfilling pharmacy or its registration class. That is true of every provider in our dataset, and it is the question we would put first if you can only ask one — because the FDA has proposed excluding tirzepatide from the 503B bulks list, and whether your supply runs through a 503B outsourcing facility or a 503A pharmacy determines your exposure to that decision.

The comparison that outranks both

Check insurance first. Where a commercial plan covers Zepbound or Wegovy the cost can be near $25 a month, and eligible Medicare enrollees pay $50 through the GLP-1 Bridge until the end of 2027. Both sit below every self-pay route including every compounded programme in our dataset.

Failing that, brand Zepbound is $299 to $449 direct from LillyDirect and both approved oral GLP-1s start at $149 — figures worth having in front of you before choosing between two compounded programmes.

Found against Lavender Sky Health, lowest figure we hold by molecule
TirzepatideFound $169Lavender Sky Health — not capturedSemaglutideFound $169Lavender Sky Health — not capturedFoundLavender Sky Health
Show this figure as a table
Data table
ItemFoundLavender Sky Health
Tirzepatide$169not captured
Semaglutide$169not captured
Solid = captured by us. Dashed = provider-reported. Hatched = no figure held. Evidence grades.
Same fields, both providers
Same fields, both providers
FieldFoundLavender Sky Health
Lowest captured all-in$169/mo—
Lowest tirzepatide$169/mo—
Lowest semaglutide$169/mo—
Records we hold40
Evidence statusProvider-reported ReportedProvider-reported Reported
Fulfilling pharmacy named to usnono
Registration class disclosednono
State availability verifiednono
Cancellation terms captured——

A dash means no figure held. How we grade evidence.

Unverified rows are shown, not dropped.
Every captured record for Found and Lavender Sky Health
ProviderProgramFormulationDose coverageMedicationRequired feesAll-in monthlyPrice typeEvidenceCaptured
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Foundprepaidcompounded injectableflat at all covered doses$169—$169Commitment tierReported2026-07-06
Foundprepaidbrand injectable, FDA-approved—$447—$447Commitment tierReported2026-07-06

NexLife, first on our v4.1 methodology, charges $129 a month for compounded tirzepatide month to month, or $115 a month on a 12-month plan, with one price at every dose and no membership fee (read on nexlife.us, November 6, 2026). Check its current plans (opens nexlife.us in a new tab).

Questions readers actually ask

Is Found cheaper than Lavender Sky Health?

We hold captured pricing for Found only, so a like-for-like price comparison is not possible yet.

Have you captured either Found or Lavender Sky Health pricing?

No. Both figures here are provider claims we have not confirmed at source, so treat the direction as indicative and the amounts as unconfirmed.

Does Found or Lavender Sky Health name its compounding pharmacy?

Neither. Two providers in our dataset do, and this is the field our rubric weights most heavily, so neither can score above 45 of 100.

Cite this pageCC BY 4.0

Tirzepatide Ranked. “Found vs Lavender Sky Health: Pricing, Evidence and What Neither Discloses.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/compare/found-vs-lavender-sky-health/

Quote the capture date beside a figure, not the date you read this page. Why.

Report an error

How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.

Comparing 0 of 4